How a cell deals with its DNA ends is a question that returns us to the very beginnings of modern telomere biology. It is also a question we are still asking today because it is absolutely essential that a cell correctly distinguishes between natural chromosomal DNA ends and broken DNA ends, then processes each appropriately – preserving the one, rejoining the other. Effective end-capping of mammalian telomeres has a seemingly paradoxical requirement for proteins more commonly associated with DNA double strand break (DSB) repair. Ku70, Ku80, DNA-PKcs (the catalytic subunit of DNA-dependent protein kinase), Xrcc4 and Artemis all participate in DSB repair through nonhomologous end-joining (NHEJ). Somewhat surprisingly, mutations in any of these genes cause spontaneous chromosomal end-to-end fusions that maintain large blocks of telomeric sequence at the points of fusion, suggesting loss or failure of a critical terminal structure, rather than telomere shortening, is at fault. Nascent telomeres produced via leading-strand DNA synthesis are especially susceptible to these end-to-end fusions, suggesting a crucial difference in the postreplicative processing of telomeres that is linked to their mode of replication. Here we will examine the dual roles played by DNA repair proteins. Our review of this rapidly advancing field primarily will focus on mammalian cells, and cannot include even all of this. Despite these limitations, we hope the review will serve as a useful gateway to the literature, and will help to frame the major issues in this exciting and rapidly progressing field. Our apologies to those whose work we are unable to include.   

1.
d’Adda di Fagagna F, Hande MP, Tong WM, Roth D, Lansdorp PM, Wang ZQ, Jackson SP: Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr Biol 11:1192–1196 (2001).
2.
d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP: A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194–198 (2003).
3.
Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA: Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406:641–645 (2000).
4.
Bailey SM, Meyne J, Chen DJ, Kurimasa A, Li GC, Lehnert BE, Goodwin EH: DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc natl Acad Sci, USA 96:14899–14904 (1999).
5.
Bailey SM, Cornforth MN, Kurimasa A, Chen DJ, Goodwin EH: Strand-specific postreplicative processing of mammalian telomeres. Science 293:2462–2465 (2001).
6.
Bailey SM, Brenneman MA, Halbrook J, Nickoloff JA, Ullrich RL, Goodwin EH: The kinase activity of DNA-PK is required to protect mammalian telomeres. DNA Repair (Amst), in press (2004).
7.
Bianchi A, deLange T: Ku binds telomeric DNA in vitro. J biol Chem 274:21223–21227 (1999).
8.
Biessmann H, Mason JM: Genetics and molecular-biology of telomeres. Adv Genet 30:185–249 (1992).
9.
Blackburn EH: Structure and function of telomeres. Nature 350:569–573 (1991).
10.
Blackburn EH, Bradley J, Greider C, Lee M, Romero D, Shippenlentz D, Yu GL: Synthesis of telomeres by the ribonucleoprotein telomerase. FASEB J 5:A1784–A1784 (1991).
11.
Blunt T, Gell D, Fox M, Taccioli GE, Lehmann AR, Jackson SP, Jeggo PA: Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc natl Acad Sci, USA 93:10285–10290 (1996).
12.
Bryan TM, Reddel RR: Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33:767–773 (1997).
13.
Cadwell C, Zambetti GP: The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 277:15–30 (2001).
14.
Campisi J, Kim SH, Lim CS, Rubio M: Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol 36:1619–1637 (2001).
15.
Carney JP, Maser RS, Olivares H, Davis EM, LeBeau M, Yates JR, Hays L, Morgan WF, Petrini JHJ: The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477–486 (1998).
16.
Cimino-Reale G, Pascale E, Alvino E, Starace G, D’Ambrosio E: Long telomeric C-rich 5′-tails in human replicating cells. J biol Chem 278:2136–2140 (2003).
17.
DePinho RA, Wong KK: The age of cancer: telomeres, checkpoints, and longevity. J Clin Invest 111:S9–14 (2003).
18.
Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE, Ried T, Nussenzweig A, Max E: DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation; Ku80 is essential for maintaining genomic stability. Nature 404:510–514 (2000).
19.
Donoho G, Brenneman MA, Cui TX, Donoviel D, Vogel H, Goodwin EH, Chen DJ, Hasty P: Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice. Genes Chrom Cancer 36:317–331 (2003).
20.
Epstein CJ, Motulsky AG: Werner syndrome: entering the helicase era. Bioessays 18:1025–1027 (1996).
21.
Espejel S, Franco S, Rodriguez-Perales S, Bouffler SD, Cigudosa JC, Blasco MA: Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J 21:2207–2219 (2002a).
22.
Espejel S, Franco S, Sgura A, Gae D, Bailey SM, Taccioli GE, Blasco MA: Functional interaction between DNA-PKcs and telomerase in telomere length maintenance. EMBO J 21:6275–6287 (2002b).
23.
di Fagagna FD, Hande MP, Tong WM, Lansdorp PM, Wang ZQ, Jackson SP: Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nature Genet 23:76–80 (1999).
24.
Feldser DM, Hackett JA, Greider CW: Telomere dysfunction and the initiation of genome instability. Nature Rev Cancer 3:623–627 (2003).
25.
Ferguson DO, Sekiguchi JM, Chang S, Frank KM, Gao Y, DePinho RA, Alt FW: The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc natl Acad Sci, USA 97:6630–6633 (2000).
26.
Franklin R, Gosling R: Molecular configuration in sodium thymonucleate. Nature 171:740–741 (1953).
27.
Gage BM, Alroy D, Shin CY, Ponomareva ON, Dhar S, Sharma GG, Pandita TK, Thayer MJ, Turker MS: Spontaneously immortalized cell lines obtained from adult Atm null mice retain sensitivity to ionizing radiation and exhibit a mutational pattern suggestive of oxidative stress. Oncogene 20:4291–4297 (2001).
28.
Gell D, Jackson SP: Mapping of protein-protein interactions within the DNA-dependent protein kinase complex. Nucl Acids Res 27:3494–3502 (1999).
29.
Gilley D, Tanaka H, Hande MP, Kurimasa A, Li GC, Oshimura M, Chen DJ: DNA-PKcs is critical for telomere capping. Proc natl Acad Sci, USA 98:15084–15088 (2001).
30.
Goedecke W, Eijpe M, Offenberg HH, vanAalderen M, Heyting C: Mre11 and Ku70 interact in somatic cells; but are differentially expressed in early meiosis. Nature Genetics 23:194–198 (1999).
31.
Gollahon LS, Kraus E, Wu TA, Yim SO, Strong LC, Shay JW, Tainsky MA: Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene 17:709–717 (1998).
32.
Gottlieb TM, Jackson SP: The DNA-dependent protein-kinase: requirement for DNA ends and association with Ku antigen. Cell 72:131–142 (1993).
33.
Goytisolo FA, Samper E, Edmonson S, Taccioli GE, Blasco MA: The absence of the DNA-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol Cell Biol 21:3642–3651 (2001).
34.
Gray MD, Shen JC, Kamath-Loeb AS, Blank A, Sopher BL, Martin GM, Oshima J, Loeb LA: The Werner syndrome protein is a DNA helicase. Nature Genet 17:100–103 (1997).
35.
Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, deLange T: Mammalian telomeres end in a large duplex loop. Cell 97:503–514 (1999).
36.
Gu YS, Jin SF, Gao YJ, Weaver DT, Alt FW: Ku70-deficient embryonic stem-cells have increased ionizing radiosensitivity; defective-DNA end-binding activity; and inability to support V(D)J recombination. Proc natl Acad Sci, USA 94:8076–8081 (1997).
37.
Harley CB, Vaziri H, Counter CM, Allsopp RC: The telomere hypothesis of cellular aging. Exp Geront 27:375–382 (1992).
38.
Hasty P, Campisi J, Hoeijmakers J, van Steeg H, Vijg J: Aging and genome maintenance: lessons from the mouse? Science 299:1355–1359 (2003).
39.
Hsu HL, Gilley D, Blackburn EH, Chen DJ: Ku is associated with the telomere in mammals. Proc natl Acad Sci, USA 96:12454–12458 (1999).
40.
Huang SR, Li BM, Gray MD, Oshima J, Mian SI, Campisi J: The premature ageing syndrome protein; WRN; is a 3′-5′ exonuclease. Nature Genet 20:114–116 (1998).
41.
Jaco I, Munoz P, Goytisolo F, Wesoly J, Bailey S, Taccioli G, Blasco MA: Role of mammalian Rad54 in telomere length maintenance. Mol Cell Biol 23:5572–5580 (2003).
42.
Kashishian A, Douangpanya H, Clark D, Schlachter ST, Eary CT, Schiro JG, Huang H, Burgess LE, Kesicki EA, Halbrook J: DNA-dependant protein kinase inhibitors as drug candidates for the treatment of cancer. Mol Cancer Ther 2:1257–1264 (2003).
43.
Kraakman-vanderZwet M, Overkamp WJ, Friedl AA, Klein B, Verhaegh G, Jaspers NG, Midro AT, Eckardt-Schupp F, Lohman PHM, Zdzienicka MZ: Immortalization and characterization of Nijmegen Breakage syndrome fibroblasts. Mutat Res 434:17–27 (1999).
44.
Kurimasa A, Kumano S, Boubnov NV, Story MD, Tung CS, Peterson SR, Chen DJ: Requirement for the kinase activity of human DNA-dependent protein kinase catalytic subunit in DNA strand break rejoining. Mol Cell Biol 19:3877–3884 (1999a).
45.
Kurimasa A, Ouyang H, Dong LJ, Wang S, Li XL, Cordon-Cardo C, Chen DJ, Li GC: Catalytic subunit of DNA-dependent protein kinase: Impact on lymphocyte development and tumorigenesis. Proc natl Acad Sci, USA 96:1403–1408 (1999b).
46.
de Lange T: Protection of mammalian telomeres. Oncogene 21:532–540 (2002).
47.
Leesmiller SP, Godbout R, Chan DW, Weinfeld M, Day RS, Barron GM, Allalunisturner J: Absence of P350 subunit of DNA-activated protein-kinase from a radiosensitive human cell-line. Science 267:1183–1185 (1995).
48.
Ma Y, Pannicke U, Schwarz K, Lieber MR: Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108:781–794 (2002).
49.
Makarov VL, Hirose Y, Langmore JP: Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88:657–666 (1997).
50.
McClintock B: The stability of broken ends of chromosomes in Zea mays. Genetics 26:234–282 (1941).
51.
McClintock B: The fusion of broken ends of chromosomes following nuclear fusion. Proc natl Acad Sci, USA 28:458–463 (1942).
52.
Meek K, Kienker L, Dallas C, Wang W, Dark MJ, Venta PJ, Huie ML, Hirschhorn R, Bell T: SCID in Jack Russell terriers: a new animal model of DNA-PKcs deficiency. J Immunol 167:2142–2150 (2001).
53.
Meyne J, Ratliff RL, Moyzis RK: Conservation of the human telomere sequence (TTAGGG)N among vertebrates. Proc natl Acad Sci, USA 86:7049–7053 (1989).
54.
Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F, Tezcan I, Sanal O, Bertrand Y, Philippe N, Fischer A, de Villartay JP: Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177–186 (2001).
55.
Muller H: The remaking of chromosomes. The Collecting Net Woods Hole 13:181–198 (1938).
56.
Murnane JP, Sabatier L, Marder BA, Morgan WF: Telomere dynamics in an immortal human cell-line. EMBO J 13:4953–4962 (1994).
57.
Okano S, Lan L, Caldecott KW, Mori T, Yasui A: Spatial and temporal cellular responses to single-strand breaks in human cells. Mol Cell Biol 23:3974–3981 (2003).
58.
Okayasu R, Suetomi K, Yu Y, Silver A, Bedford JS, Cox R, Ullrich RL: A deficiency in DNA repair and DNA-PKcs expression in the radiosensitive BALB/c mouse. Cancer Res 60:4342–4345 (2000).
59.
Pandita TK, Pathak S, Geard CR: Chromosome end associations; telomeres and telomerase activity in ataxia-telangiectasia cells. Cytogenet Cell Genet 71:86–93 (1995).
60.
Pluth JM, Fried LM, Kirchgessner CU: Severe combined immunodeficient cells expressing mutant hRAD54 exhibit a marked DNA double-strand break repair and error-prone chromosome repair defect. Cancer Res 61:2649–2655 (2001).
61.
Rogakou EP, Boon C, Redon C, Bonner WM: Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146:905–916 (1999).
62.
Rooney S, Sekiguchi J, Zhu C, Cheng HL, Manis J, Whitlow S, DeVido J, Foy D, Chaudhuri J, Lombard D, Alt FW: Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell 10:1379–1390 (2002).
63.
Rooney S, Alt FW, Lombard D, Whitlow S, Eckersdorff M, Fleming J, Fugmann S, Ferguson DO, Schatz DG, Sekiguchi J: Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J exp Med 197:553–565 (2003).
64.
Rothkamm K, Lobrich M: Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc natl Acad Sci, USA 100:5057–5062 (2003).
65.
Samper E, Goytisolo FA, Slijepcevic P, van Vuul PPW, Blasco MA: Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Reports 1:244–252 (2000).
66.
Samper E, Goytisolo FA, Menissier-de Murcia J, Gonzalez-Suarez E, Cigudosa JC, de Murcia G, Blasco MA: Normal telomere length and chromosomal end capping in poly(ADP-ribose) polymerase-deficient mice and primary cells despite increased chromosomal instability. J Cell Biol 154:49–60 (2001).
67.
Singleton BK, Torres-Arzayus MI, Rottinghaus ST, Taccioli GE, Jeggo PA: The C terminus of Ku80 activates the DNA-dependent protein kinase catalytic subunit. Mol Cell Biol 19:3267–3277 (1999).
68.
Slijepcevic P, Hande MP, Bouffler SD, Lansdorp P, Bryant PE: Telomere length, chromatin structure and chromosome fusigenic potential. Chromosoma 106:413–421 (1997).
69.
Smogorzewska A, Karlseder J, Holtgreve-Grez H, Jauch A, de Lange T: DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr Biol 12:1635 (2002).
70.
van Steensel B, Smogorzewska A, de Lange T: TRF2 protects human telomeres from end-to-end fusions. Cell 92:401–413 (1998).
71.
Szumiel I: Monitoring and signaling of radiation-induced damage in mammalian cells. Radiat Res 150:S92–101 (1998).
72.
Thompson LH, Schild D: Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat Res 477:131–153 (2001).
73.
Tong WM, Hande MP, Lansdorp PM, Wang ZQ: DNA strand break-sensing molecule poly(ADP-Ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression. Mol Cell Biol 21:4046–4054 (2001).
74.
Walker JR, Corpina RA, Goldberg J: Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 412:607–614 (2001).
75.
Wang H, Perrault AR, Takeda Y, Qin W, Iliakis G: Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucl Acids Res 31:5377–5388 (2003).
76.
Watson JD: Origin of concatameric T4 DNA. Nature 239:197–201 (1972).
77.
Watson JD, Crick FH: Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171:737–738 (1953).
78.
Wellinger RJ, Sen D: The DNA structures at the ends of eukaryotic chromosomes. Eur J Cancer 33:735–749 (1997).
79.
Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW: Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Development 11:2801–2809 (1997).
80.
Yu Y, Okayasu R, Weil MM, Silver A, McCarthy M, Zabriskie R, Long S, Cox R, Ullrich RL: Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene. Cancer Res 61:1820–1824 (2001).
81.
von Zglinicki T, Saretzki G, Docke W, Lotze C: Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 220:186–193 (1995).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.